Importance of mitral regurgitation in patients undergoing percutaneous coronary intervention for acute myocardial infarction: The Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) Trial

Journal of the American College of Cardiology

Volumn 43, Issue 8, 2004, Pages 1368-1374

  Pellizzon, Gregory G ^a   Grines, Cindy L ^b   Cox, David A ^c   Stuckey, Thomas ^d   Tcheng, James E ^e   Garcia, Eulogio ^f   Guagliumi, Giulio ^g   Turco, Mark ^h   Lansky, Alexandra J ^k   Griffin, John J ⁱ   Cohen, David J ^j   Aymong, Eve ^k   Mehran, Roxana ^k   O'Neill, William W ^b   Stone, Gregg W ^k  

^a SAINT LUKE S MID AMERICA HEART INSTITUTE   (United States)

^b WILLIAM BEAUMONT HOSPITAL   (United States)

^c Mid Carolina Cardiology   (United States)

^d MOSES H CONE MEMORIAL HOSPITAL   (United States)

^e DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^f HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^g OSPEDALI RIUNITI   (Italy)

^h WASHINGTON ADVENTIST HOSPITAL   (United States)

ⁱ Sentara Virginia Beach General Hospital   (United States)

^j BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^k CARDIOVASCULAR RESEARCH FOUNDATION   (United States)

more..

Author keywords

Acute myocardial infarction; AMI; CADILLAC; Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications; Left ventricle ventricular; LV; Mitral regurgitation; MR; PCI; Percutaneous coronary intervention; PVC

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEPARIN; PYRIDINE DERIVATIVE; STATIN; THIENOPYRIDINE; UNCLASSIFIED DRUG;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; FEMALE; FIBRINOLYTIC THERAPY; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VALVE SURGERY; HEART VENTRICULOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE REGURGITATION; MORTALITY; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; PERCUTANEOUS CORONARY INTERVENTION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; REPERFUSION;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANTIBODIES, MONOCLONAL; FEMALE; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; MALE; MIDDLE AGED; MITRAL VALVE INSUFFICIENCY; MYOCARDIAL INFARCTION; PLATELET AGGREGATION INHIBITORS; PROGNOSIS; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; STENTS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 11144354567     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2003.11.046     Document Type: Article

References (38)

1. Rankin J.S., Hickey M.S.J., Smith L.R., et al. Ischemic mitral regurgitation. Circulation. 79:(Suppl I):1989;116-121.
2. Perloff J.K., Roberts W.C. The mitral apparatus. Functional anatomy of mitral regurgitation. Circulation. 46:1972;227-239.
3. Estes E.H., Dalton F.M., Entman G.C., et al. The anatomy and blood supply of the papillary muscles of the left ventricle. Am Heart J. 71:1966;356-362.
4. Sabbah H.N., Rosman H., Kono T., et al. On the mechanism of functional mitral regurgitation. Am J Cardiol. 72:1993;1074-1076.
5. Otsuji Y., Handschumacher M.D., Liel-Cohen N., et al. Mechanism of ischemic mitral regurgitation with segmental left ventricular dysfunction Three-dimensional echocardiographic studies in models of acute and chronic progressive regurgitation. J Am Coll Cardiol. 37:2001;641-648.
6. Otsuji Y., Handschumacher M.D., Schwammental E., et al. Insights from three-dimensional echocardiography into the mechanism of functional mitral regurgitation. Direct in vivo demonstration of altered leaflet tethering geometry. Circulation. 96:1997;1999-2008.
7. Kono T., Sabbah H.N., Rosman H., et al. Mechanism of functional mitral regurgitation during acute myocardial ischemia. J Am Coll Cardiol. 19:1992;1101-1105.
8. Sharma S.K., Seckler J., Israel D.H., et al. Clinical, angiographic and anatomic findings in acute severe ischemic mitral regurgitation. Am J Cardiol. 70:1992;277-280.
9. Lehmann K.G., Francis C.K., Dodge H.T., et al. Mitral regurgitation in early myocardial infarction. Ann Intern Med. 117:1992;10-17.
10. Tcheng J.E., Jackman J.D., Nelson C.L., et al. Outcome of patients sustaining acute ischemic mitral regurgitation during myocardial infarction. Ann Intern Med. 117:1992;18-24.
11. Barzilai B., Davis V.G., Stone P.H., et al. Prognostic significance of mitral regurgitation in acute myocardial infarction. Am J Cardiol. 65:1990;1169-1175.
12. Lamas G.A., Mitchell G.F., Flaker G.C., et al. Clinical significance of mitral regurgitation after acute myocardial infarction. Circulation. 96:1997;827-833.
13. Grigioni F., Enriquez-Sarano M., Zehr K.J., et al. Ischemic mitral regurgitation. Long-term outcome and prognostic implications with quantitative Doppler assessment. Circulation. 103:2001;1759-1764.
14. Shawl F.A., Forman M.B., Punja S., et al. Emergent coronary angioplasty in the treatment of acute ischemic mitral regurgitation Long-term results in five cases. J Am Coll Cardiol. 14:1989;986-991.
15. Heuser R.R., Maddoux G.L., Goss J.E., Ramo B.W., Ruff G.L., Shadoff N. Coronary angioplasty for acute mitral regurgitation due to myocardial infarction. Ann Intern Med. 107:1987;852-855.
16. Le Feuvre C., Metzger J.P., Lachurie M.L., et al. Treatment of severe mitral regurgitation caused by ischemic papillary muscle dysfunction Indications for coronary angioplasty. Am Heart J. 123:1992;860-865.
17. Kinn J.W., O'Neill W.W., Benzuly K.H., et al. Primary angioplasty reduces risk of myocardial rupture compared to thrombolysis for acute myocardial infarction. Cathet Cardiovasc Diagn. 42:1997;151-157.
18. Stone G.W., Grines C.L., Cox D.A., et al. Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction. N Engl J Med. 346:2002;957-966.
19. Dodge H.T., Sandler H., Ballew D.W., Lord J.D. The use of biplane angiography for the measurement of left ventricular volume in man. Am Heart J. 60:1960;762-766.
20. Sheehan F.H., Bolson E.L., Dodge H.T., Mathey D.G., Schofer J., Woo H.W. Advantages and applications of the centerline chord method for characterizing regional ventricular function. Circulation. 74:1986;293-305.
21. Maisel A.S., Gilpin E.A., Klein L., et al. The murmur of papillary muscle dysfunction in acute myocardial infarction Clinical features and prognostic implications. Am Heart J. 112:1986;705-711.
22. Heikkila J. Mitral incompetence complicating acute myocardial infarction. Br Heart J. 29:1967;162-169.
23. De Servi S., Vaccari L., Assandri J., et al. Clinical significance of mitral regurgitation in patients with recent myocardial infarction. Eur Heart J. 9:(Suppl F):1988;5-9.
24. Loperfido J., Biasucci L.M., Pennestri F., et al. Pulsed Doppler echocardiographic analysis of mitral regurgitation after myocardial infarction. Am J Cardiol. 58:1986;692-697.
25. Thompson C.R., Buller C.E., Sleeper L.A., et al. Cardiogenic shock due to acute severe mitral regurgitation complicating acute myocardial infarction A report from the shock trial registry. J Am Coll Cardiol. 36:(Suppl 3A):2000;1104-1109.
26. Hochman J.S., Buller C.E., Sleeper L.A., et al. Cardiogenic shock complicating acute myocardial infarction - etiologies, management and outcome A report from the shock trial registry. J Am Coll Cardiol. 36:(Suppl 3A):2000;1063-1070.
27. Sutton M.S.J., Pfeffer M.A., Plappert T., et al. Quantitative two-dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after acute myocardial infarction. The protective effects of captopril. Circulation. 89:1994;68-75.
28. Stevenson L.W., Bellil D., Grover-McKay M., et al. Effects of afterload reduction (diuretics and vasodilators) on left ventricular volume and mitral regurgitation in severe congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol. 60:1987;654-658.
29. Migrino R.Q., Young J.B., Ellis S.G., et al. End-systolic volume index at 90 to 180 minutes into reperfusion therapy for acute myocardial infarction is a strong predictor of early and late mortality. The Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO-1) Angiographic Investigators. Circulation. 96:1997;116-121.
30. Vecchio C., Chiarella F., Lupi G., Bellotti P., Domenicucci S. Left ventricular thrombus in anterior acute myocardial infarction after thrombolysis. A GISSI-2 connected study. Circulation. 84:1991;512-519.
31. Mollet N.R., Dymarkowski S., Volders W., et al. Visualization of ventricular thrombi with contrast-enhanced magnetic resonance imaging in patients with ischemic heart disease. Circulation. 106:2002;2873-2876.
32. Ashby D.T., Stone G.W., Moses J.W. Acute myocardial infarction and cardiogenic shock. Catheter Cardiovasc Interv. 59:2003;34-43.
33. Croft C.H., Lipscomb K., Mathis K., et al. Limitations of qualitative angiographic grading in aortic or mitral regurgitation. Am J Cardiol. 53:1984;1593-1598.
34. Leor J., Feinberg M.S., Vered Z., et al. Effect of thrombolytic therapy on the evolution of significant mitral regurgitation in patients with a first inferior myocardial infarction. J Am Coll Cardiol. 21:1993;1661-1666.
35. Lehmann K.G., Francis C.K., Sheehan F.H., et al. Effect of thrombolysis on acute myocardial regurgitation during evolving myocardial infarction. Experiences from the Thrombolysis In Myocardial Infarction (TIMI) trial. J Am Coll Cardiol. 22:1993;714-719.
36. Replogle R.L., Campbell C.D. Surgery for mitral regurgitation associated with ischemic heart disease. Results and strategies. Circulation. 79:(Suppl I):1989;122-125.
37. Morishita A., Shimakura T., Nonoyama M., et al. Mitral valve replacement in ischemic mitral regurgitation. Preservation of both anterior and posterior mitral leaflets. J Cardiovasc Surg. 43:2002;147-152.
38. Rankin J.S., Feneley M.P., Hickey M.S., et al. A clinical comparison of mitral valve repair versus valve replacement in ischemic mitral regurgitation. J Thorac Cardiovasc Surg. 95:1988;165-177.